Testing effectiveness (Phase 2)Study completedNCT00157716
What this trial is testing
MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
Who this might be right for
Coronary Artery Bypass Graft SurgeryMyocardial IschemiaReperfusion Injury+1 more
Medicure 900